Get the Stockscreener App
2.58
0.00%
0.00
Revelation Biosciences Inc stock is traded at $2.58, with a volume of 58,271.
It is up +0.00% in the last 24 hours and down -10.10% over the past month.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
See More
Previous Close:
$2.58
Open:
$2.59
24h Volume:
58,271
Relative Volume:
0.06
Market Cap:
$4.39M
Revenue:
-
Net Income/Loss:
$-15.52M
P/E Ratio:
-0.1389
EPS:
-18.58
Net Cash Flow:
$-16.61M
1W Performance:
+8.40%
1M Performance:
-10.10%
6M Performance:
-39.72%
1Y Performance:
-81.99%
1-Day Range:
$2.53
$2.6186
1-Week Range:
$2.26
$2.6186
52-Week Range:
$0.702
$56.00
Revelation Biosciences Inc Stock (REVB) Company Profile
Name
Revelation Biosciences Inc
Sector
Industry
Phone
650-800-3717
Address
4660 LAJOLLA VILLAGE DRIVE, SAN DIEGO
Compare REVB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
REVB
Revelation Biosciences Inc
|
2.58 | 4.39M | 0 | -15.52M | -16.61M | -18.58 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Revelation Biosciences Inc Stock (REVB) Latest News
Measuring Revelation Biosciences Inc. Equity Warrant’s beta against major indicesJuly 2025 Final Week & Expert Approved Trade Ideas - Newser
Does Revelation Biosciences Inc. have declining or rising EPSJuly 2025 Rallies & High Accuracy Trade Alerts - thegnnews.com
Published on: 2025-08-17 03:23:14 - Newser
Can trapped investors hope for a rebound in Revelation Biosciences Inc.Rate Hike & Low Risk Investment Opportunities - Newser
Will Revelation Biosciences Inc. Equity Warrant benefit from macro trendsJuly 2025 Outlook & Fast Exit/Entry Strategy Plans - Newser
Custom watchlist performance reports with Revelation Biosciences Inc.Portfolio Update Report & Weekly High Potential Stock Alerts - Newser
Why Revelation Biosciences Inc. Equity Warrant stock attracts strong analyst attention2025 Key Highlights & High Return Stock Watch Alerts - Newser
How Revelation Biosciences Inc. stock performs during market volatilityInsider Buying & Daily Entry Point Trade Alerts - Newser
Is Revelation Biosciences Inc. Equity Warrant a candidate for recovery playCEO Change & AI Based Buy and Sell Signals - Newser
Is it too late to sell Revelation Biosciences Inc.2025 Retail Activity & Free Daily Entry Point Trade Alerts - Newser
Tick level data insight on Revelation Biosciences Inc. volatility2025 Institutional Moves & Accurate Trade Setup Notifications - Newser
Applying big data sentiment scoring on Revelation Biosciences Inc. Equity Warrant - Newser
What MACD signals say about Revelation Biosciences Inc.Earnings Performance Report & Risk Managed Investment Entry Signals - Newser
Exit strategy if you’re trapped in Revelation Biosciences Inc. Equity WarrantEarnings Miss & AI Driven Stock Price Forecasts - Newser
Using Ichimoku Cloud for Revelation Biosciences Inc. Equity Warrant technicals2025 Momentum Check & Daily Stock Momentum Reports - Newser
Published on: 2025-08-16 02:57:08 - Newser
How to monitor Revelation Biosciences Inc. Equity Warrant with trend dashboardsQuarterly Risk Review & Safe Capital Growth Trade Ideas - Newser
What momentum shifts mean for Revelation Biosciences Inc. Equity Warrant2025 Bull vs Bear & Growth-Oriented Investment Plans - Newser
Will breakout in Revelation Biosciences Inc. Equity Warrant lead to full recovery2025 Bull vs Bear & Daily Entry Point Trade Alerts - Newser
How moving averages guide Revelation Biosciences Inc. tradingJuly 2025 Sentiment & Weekly Breakout Stock Alerts - Newser
Will Revelation Biosciences Inc. benefit from macro trends2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
Statistical indicators supporting Revelation Biosciences Inc.’s strengthMarket Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Backtesting results for Revelation Biosciences Inc. Equity Warrant trading strategies - Newser
Top chart patterns to watch in Revelation Biosciences Inc. Equity WarrantWeekly Stock Report & Weekly Setup with High ROI Potential - Newser
How to build a custom watchlist for Revelation Biosciences Inc.Weekly Trade Review & Safe Entry Momentum Stock Tips - Newser
Regression analysis insights on Revelation Biosciences Inc. Equity Warrant performance2025 Trading Recap & Long Hold Capital Preservation Tips - Newser
Custom watchlist performance reports with Revelation Biosciences Inc. Equity WarrantMarket Risk Analysis & Consistent Profit Trading Strategies - Newser
Quantitative breakdown of Revelation Biosciences Inc. recent moveQuarterly Profit Review & Short-Term High Return Strategies - Newser
Applying big data sentiment scoring on Revelation Biosciences Inc.2025 Breakouts & Breakdowns & Free Expert Approved Momentum Trade Ideas - Newser
Is Revelation Biosciences Inc. stock entering bullish territoryQuarterly Market Review & Real-Time Volume Trigger Notifications - Newser
Is Revelation Biosciences Inc. a defensive stockEarnings Overview Summary & AI Enhanced Market Trend Forecasts - thegnnews.com
Applying chart zones and confluence areas to Revelation Biosciences Inc. Equity WarrantGold Moves & High Accuracy Investment Signals - Newser
Does Revelation Biosciences Inc. outperform in volatile marketsEarnings Performance Report & Risk Adjusted Swing Trade Ideas - sundaytimes.kr
What analysts say about Revelation Biosciences Inc. stock2025 Technical Overview & Weekly Momentum Stock Picks - thegnnews.com
What makes Revelation Biosciences Inc. stock price move sharplyWeekly Trade Analysis & Fast Moving Stock Trade Plans - Newser
Published on: 2025-08-15 11:15:13 - sundaytimes.kr
Long term hold vs stop loss in Revelation Biosciences Inc.2025 Breakouts & Breakdowns & High Conviction Trade Alerts - Newser
Published on: 2025-08-14 01:40:36 - Newser
Revelation Biosciences Inc Stock (REVB) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):